Skip to content

NantHealth, Inc.

CIK 0001566469

← back to feed
Revenue (TTM)
$63.41M
+6.9% YoY Q3 Nov 2023
Net Income (TTM)
−$58.37M
−16.3% YoY Q3 Nov 2023
EPS Diluted (TTM)
−$6.63
−14.9% YoY Q3 Nov 2023
Gross Margin
61.4%
Q3 Nov 2023
Operating Margin
-72.0%
Q3 Nov 2023
Net Margin
-92.1%
Q3 Nov 2023
Free Cash Flow (TTM)
−$34.6M
Q3 Nov 2023
Cash
$5.82M
Q3 Nov 2023
Total Debt
—
Q3 Nov 2023
Shares Outstanding
27.47M sh
Q3 Nov 2023

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings